Nutritional composition useful in the treatment of IBD patients

A method for achieving a result selected from the group consisting of treatment of inflammatory bowel disease (IBD), prolonging remission of IBD, and maintaining or improving the mucosa health status of a patient having IBD or in remission from IBD, the method comprising:

• administering a composition comprising (a) free form amino acids comprising 9.0-11.0 g threonine in free form/100 g of the composition, 7.0-10.0 g serine in free form/100 g of the composition, and 7.0-9.0 g proline in free form/100 g of the composition;
• (b) carbohydrates and proteins comprising whey TGF-Beta;
• and (c) at least one essential fatty acid to the patient,
• the carbohydrates are 10-50 energy percent of the composition, total proteins comprising the free form amino acids and the proteins comprising the whey TGF-Beta are 30-60 energy percent of the composition, and fats comprising the at least one essential fatty acid are 10-40 energy percent of the composition,
• the patient has initiated therapy comprising at least one of infliximab or adalimumab at least 12 weeks prior to initiating the administering of the composition to the patient.